Skip to main content

CVS HEALTH Corp cash flow statement

  • CVS · NYSE
  • Retail
  • Health Care Services
  • S&P 500
$89.35−0.49%Close 13 Nov 2026 · Market value $113.1B

In fiscal 2025 (the year to 31 Dec 2025), CVS HEALTH Corp generated $10.64B of operating cash flow and $7.81B of free cash flow, after $2.83B of capital expenditure.

From CVS HEALTH Corp's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

CVS HEALTH Corp cash flow statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$2.64B$3.20B$3.70B$3.43B$3.46B$3.86B$4.59B$4.64B$5.24B$5.32B$6.62B−$594.0M$6.63B$7.18B$8.00B$4.31B$8.34B$4.61B$1.77B$11.04B
Depreciation & amortization$1.09B$1.27B$1.39B$1.47B$1.57B$1.75B$1.87B$1.93B$2.09B$2.48B$2.48B$2.72B$4.37B$4.44B$4.49B$4.22B$4.37B$4.60B$4.61B$4.52B
Stock-based compensation$78.00M$92.00M$165.0M$150.0M$135.0M$132.0M$141.0M$165.0M$230.0M$222.0M$234.0M$280.0M$453.0M$400.0M$484.0M$447.0M$588.0M$540.0M$535.0M$745.0M
Operating cash flow$3.23B$3.95B$4.04B$4.78B$5.86B$6.67B$5.78B$8.14B$8.54B$10.14B$8.01B$8.87B$12.85B$15.87B$18.27B$16.18B$13.43B$9.11B$10.64B$18.71B
Operating cash flow margin4.2%4.5%4.1%5.0%5.5%5.4%4.6%5.8%5.6%5.7%4.3%4.6%5.0%5.9%6.3%5.0%3.8%2.4%2.6%4.4%
Capital expenditures$1.80B$2.18B$2.55B$2.00B$1.87B$2.03B$1.98B$2.14B$2.37B$2.22B$1.92B$2.04B$2.46B$2.44B$2.52B$2.73B$3.03B$2.78B$2.83B$3.14B
Acquisitions$1.98B$2.65B$101.0M$177.0M$1.44B$378.0M$415.0M$2.44B$11.47B$524.0M$1.18B$42.23B$444.0M$866.0M$146.0M$139.0M$16.61B$95.00M$436.0M$22.00M
Free cash flow$1.43B$1.77B$1.49B$2.77B$3.98B$4.64B$3.80B$6.00B$6.17B$7.92B$6.09B$6.83B$10.39B$13.43B$15.74B$13.45B$10.39B$6.33B$7.81B$15.57B
Free cash flow margin1.9%2.0%1.5%2.9%3.7%3.8%3.0%4.3%4.0%4.5%3.3%3.5%4.0%5.0%5.4%4.2%2.9%1.7%1.9%3.7%
Free cash flow per share$1.04$1.20$1.03$2.01$2.96$3.63$3.10$5.13$5.48$7.34$5.95$6.54$7.96$10.22$11.85$10.17$8.06$5.01$6.14$12.11
Dividends paid$323.0M$383.0M$439.0M$479.0M$674.0M$829.0M$1.10B$1.29B$1.58B$1.84B$2.05B$2.04B$2.60B$2.62B$2.63B$2.91B$3.13B$3.37B$3.40B$3.42B
Gross share repurchases$5.37B$23.00M$2.48B$1.50B$3.00B$4.33B$3.98B$4.00B$5.00B$4.46B$4.36B$0.00$0.00$0.00$0.00$3.50B$2.01B$3.02B$0.00—
Stock issuance proceeds$553.0M$328.0M$250.0M$285.0M$431.0M$836.0M$500.0M$421.0M$362.0M$296.0M$329.0M$242.0M$210.0M$264.0M$549.0M$551.0M$277.0M$361.0M$394.0M$425.0M
Net share repurchases$4.82B−$305.0M$2.23B$1.22B$2.57B$3.49B$3.48B$3.58B$4.64B$4.17B$4.03B−$242.0M−$210.0M−$264.0M−$549.0M$2.95B$1.74B$2.66B−$394.0M−$425.0M
Cash interest paid$468.0M$574.0M$542.0M$583.0M$647.0M$581.0M$534.0M$647.0M$629.0M$1.14B$1.07B$2.80B$2.95B$2.90B$2.47B$2.24B$2.42B$2.91B$2.99B$3.05B
Free cash flow after SBC$1.35B$1.68B$1.32B$2.62B$3.85B$4.51B$3.66B$5.84B$5.94B$7.70B$5.86B$6.55B$9.94B$13.03B$15.26B$13.00B$9.81B$5.79B$7.27B$14.82B

Quarterly

CVS HEALTH Corp cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$2.05B$1.11B$1.77B$87.00M$1.64B$1.78B$1.02B−$3.98B$2.94B$2.94B$2.98B$2.17B
Depreciation & amortization$1.13B$1.14B$1.15B$1.16B$1.15B$1.15B$1.17B$1.13B$1.15B$1.11B$1.13B$1.13B
Stock-based compensation$127.0M$137.0M$133.0M$133.0M$137.0M$126.0M$136.0M$138.0M$135.0M$266.0M$176.0M$168.0M
Operating cash flow−$2.64B$4.90B$3.09B−$745.0M$1.86B$4.56B$1.90B$796.0M$3.39B$4.25B$6.34B$4.72B
Operating cash flow margin−2.8%5.5%3.4%−0.8%1.9%4.8%1.9%0.8%3.2%4.2%6.0%4.4%
Capital expenditures$911.0M$705.0M$638.0M$670.0M$768.0M$743.0M$607.0M$698.0M$784.0M$849.0M$691.0M$817.0M
Acquisitions$120.0M$25.00M$48.00M$12.00M$10.00M$20.00M$119.0M$290.0M$7.00M$5.00M$4.00M$6.00M
Free cash flow−$3.55B$4.20B$2.45B−$1.42B$1.09B$3.81B$1.29B$98.00M$2.61B$3.40B$5.65B$3.91B
Free cash flow margin−3.8%4.7%2.7%−1.5%1.1%4.0%1.3%0.1%2.5%3.4%5.3%3.6%
Free cash flow per share−$2.74$3.31$1.95−$1.12$0.87$3.02$1.02$0.08$2.03$2.66$4.39$3.03
Dividends paid$779.0M$840.0M$858.0M$837.0M$838.0M$840.0M$866.0M$846.0M$845.0M$847.0M$878.0M$853.0M
Gross share repurchases$1.00M$3.03B$3.00M$1.00M$0.00$0.00$0.00$0.00$0.00———
Stock issuance proceeds$35.00M$203.0M$25.00M$114.0M$19.00M$144.0M$47.00M$117.0M$86.00M$103.0M$114.0M$122.0M
Net share repurchases−$34.00M$2.82B−$22.00M−$113.0M−$19.00M−$144.0M−$47.00M−$117.0M−$86.00M−$103.0M−$114.0M−$122.0M
Cash interest paid$369.0M$1.04B$349.0M$999.0M$518.0M$1.01B$472.0M$1.04B$462.0M$1.09B$460.0M$1.03B
Free cash flow after SBC−$3.67B$4.06B$2.32B−$1.55B$955.0M$3.69B$1.15B−$40.00M$2.47B$3.13B$5.48B$3.74B

The main figures as JSON and plain text. See data and methodology.

CVS in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.